DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "OTC Distribution in Europe 2016 Edition: The New Global Agenda " report to their offering.
OTC Distribution in Europe - the 2016 edition is a long running in-depth study that explores and tracks change. It identifies the driving factors coming into play which will influence the distribution channel environment for the consumer healthcare industry now and in the future. It provides a wealth of knowledge and comprehensive statistics and analysis covering 20 European countries, together with insights into an increasingly complex market sector from a highly respected strategy consultant, James W Dudley.
A new and rapidly evolving competitive agenda is enveloping the supply networks which serve 473 million people living in 20 European countries with 29 billion worth of consumer health products.
Merger and acquisition activities are globalizing the supply chain and intensifying competitive pressures. Cross border mixed pharmacy chains are reshaping the consumer channel. Powerful retail brands employ digital technologies to drive multi-channel strategies and Internet pharmacies are undermining consumer prices.
Independent pharmacies are forming collectives, affiliated groupings and virtual chains in an attempt to remain competitive. Reducing government payments toward reimbursed prescription drugs and pressures on fees are forcing pharmacies to seek business from non price regulated consumer care ranges. Furthermore, deregulation of the non-prescription healthcare sector is shifting consumer demand to non-pharmacy channels in a number of countries.
Examples of findings of this new 20 country study are:
- 85% of the consumer health market turnover passes through 145,143 pharmacies, while 15% is accessed through supermarkets, discounters, convenience stores, druggists and Internet and mail order pharmacies
- 15% of European pharmacies are branches of wholly owned pharmacy multiples many of them international chains
- One in three European pharmacies is a member of a virtual chain' or affiliated cooperation group of independent pharmacies
- Internet pharmacies are playing an increasing role in consumers sources and choices of purchases for consumer healthcare and related products and services especially in Germany, the UK and Belgium
- Nearly half of the intermediary pharmaceutical wholesale market is controlled by a handful of players
Key Topics Covered:
Chapter 1 Distribution of OTC Medicines in Europe - Introduction, Market Definitions and Summary of Key Issues
Chapter 2 Pharmaceutical Distributors New Strategies in Europe
Chapter 3 Profiles of Companies Driving the European Pharmaceutical Supply Chain
Chapter 4 New Channels for Consumer Healthcare in Europe
Chapter 5 OTC Distribution in Belgium
Chapter 6 OTC Distribution in France
Chapter 7 OTC Distribution in Germany
Chapter 8 OTC Distribution in Italy
Chapter 9 OTC Distribution in the Netherlands
Chapter 10 OTC Distribution in Spain
Chapter 11 OTC Distribution in the United Kingdom
Chapter 12 OTC Distribution in Austria & Switzerland
Chapter 13 OTC Distribution in the Nordic Region
Chapter 14 OTC Distribution in Central Europe
Chapter 15 Conclusions of the Report
Companies Mentioned - Partial List
- A.S. Watson
- AAH Pharmaceuticals (Celesio)
- AAH Wilkinson Healthcare
- Alliance Healthcare (WBA) Previously SA Farmacéutica Aragonesia (SAFA)
- Alma Patika
- Almus
- AmedisUE
- AmerisourceBergen
- Apokjeden Tamro
- Apoteket AB
- Apoteket AB
- Apoteksgruppen
- Apotheke zur Rose
- Astera CERP Rouen
- Auchan
- BENU Pharmacy
- Belmedis Welcoop
- Benu (Phoenix )
- Benu Apotheek (Escura Apotheek)
- Benue Phoenix
- Bestway Group
- Boots
- Brocacef Holdings Benu Pharmacy
- CEFARM Pharmaceutical SA
- CERP Lorraine
- CERP SA Astera cooperative group
- COFARES Spain
- Carrefour
- Catena
- Cecofar
- Cefarm 24
- Celesio Italy
- Cohens Chemist
- Cosmetic Products
For more information visit http://www.researchandmarkets.com/research/z79nxm/otc_distribution
